http://www.springerlink.com/content/w63656q2062g2818/
Clinical experience with high-dose idebenone in Friedreich ataxia
Jörg B. Schulz1 , Nicholas A. Di Prospero2 and Kenneth Fischbeck3
(1) Dept. of Neurology, University Medical Centre, RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany
(2) Johnson and Johnson Pharmaceutical Research and Development, Raritan, NJ, USA
(3) Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, MD, USA